more_reports

CytoDyn Inc.

CYDY:OTCQB

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab (PRO 140), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 appears to play a key role in the ability of HIV to enter and infect healthy T-cells.

streetwise book logo Streetwise Company Fact Sheet

2024/7/14 0:36:18

(CYDY:OTCQB)